Product Information
STRIBILD TABLET is a brand product labeled by Gilead Sciences, Inc., priced at $149.6307 per EA under NDC 61958120101. Its NADAC has been published 649 times since Nov 28, 2013.
STRIBILD TABLET
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarateStrength
150; 150; 200; 300 mg/1; mg/1; mg/1; mg/1
Manufacturer
Gilead Sciences, Inc.NDC
61958120101
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATEApproval Type
New Drug (NDA)
FDA Application
NDA203100On Market Since
8/27/2012
Pharmacological Classes
Price Statistics
The NADAC for STRIBILD TABLET has been published 649 times since Nov 28, 2013, and over the history we have for it it has risen 98.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $149.6307 per EA |
|---|---|
| All-time high | $150.4090 (May 13, 2026) |
| All-time low | $75.4777 (Nov 28, 2013) |
| 52-week high | $150.4090 |
| 52-week low | $142.9515 |
| Median price | $110.0398 |
| Average price | $110.2847 |
| Largest weekly change | +6.9% (Jul 13, 2016) |
| Weeks tracked | 649 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of STRIBILD TABLET?
The current National Average Drug Acquisition Cost (NADAC) for STRIBILD TABLET, manufactured by Gilead Sciences, Inc., is $149.6307 per EA (NDC 61958120101), effective Jun 24, 2026.
How has the price of STRIBILD TABLET changed over time?
Over the history we have for it, the NADAC for STRIBILD TABLET has risen 98.2%. It has been tracked across 649 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for STRIBILD TABLET?
Since Nov 28, 2013, the NADAC for STRIBILD TABLET has ranged from a low of $75.4777 (Nov 28, 2013) to a high of $150.4090 (May 13, 2026), with a median of $110.0398 per EA.
Are there cheaper alternatives to STRIBILD TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of STRIBILD TABLET, so no direct lower-cost alternative is listed.
Who manufactures STRIBILD TABLET?
STRIBILD TABLET (NDC 61958120101) is labeled by Gilead Sciences, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification